BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3413737)

  • 1. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
    Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
    Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
    Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern.
    Leone G; De Stefano V; Di Donfrancesco A; Ferrelli R; Traisci G; Bizzi B
    Br J Haematol; 1987 Feb; 65(2):187-91. PubMed ID: 3828226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new familial variant of antithrombin III: 'antithrombin III Paris'.
    Wolf M; Boyer C; Lavergne JM; Larrieu MJ
    Br J Haematol; 1982 Jun; 51(2):285-95. PubMed ID: 7082587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma).
    De Stefano V; Leone G; Ferrelli R; Di Donfrancesco A; De Martini D; Bizzi B
    Thromb Res; 1987 Oct; 48(1):23-30. PubMed ID: 3424283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.
    Sakuragawa N; Takahashi K; Kondo S; Koide T
    Thromb Res; 1983 Jul; 31(2):305-17. PubMed ID: 6636045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing.
    Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B
    Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
    Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN
    Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
    Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
    Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
    Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
    Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III gene.
    Bock SC; Harris JF; Schwartz CE; Ward JH; Hershgold EJ; Skolnick MH
    Am J Hum Genet; 1985 Jan; 37(1):32-41. PubMed ID: 2983542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect.
    De Stefano V; Leone G; De Carolis MP; Ferrelli R; De Carolis S; Pagano L; Tortorolo G; Bizzi B
    Thromb Haemost; 1987 Jun; 57(3):329-31. PubMed ID: 3660333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of inherited antithrombin III deficiencies.
    Prochownik EV
    Am J Med; 1989 Sep; 87(3B):15S-18S. PubMed ID: 2572168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
    Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An abnormal plasma antithrombin with no apparent affinity for heparin.
    Chasse JF; Esnard F; Guitton JD; Mouray H; Perigois F; Fauconneau G; Gauthier F
    Thromb Res; 1984 May; 34(4):297-302. PubMed ID: 6204398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a new antithrombin III familial variant (AT Dublin) with possible increased frequency in children with cancer.
    Daly M; O'Meara A; Hallinan FM
    Br J Haematol; 1987 Apr; 65(4):457-62. PubMed ID: 3472589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.